Autor: |
S A, Mirzoian, A A, Petrosian, S A, Arutiunian, T G, Gukasian, O S, Medvedev, E A, Shirinian |
Rok vydání: |
2000 |
Předmět: |
|
Zdroj: |
Eksperimental'naia i klinicheskaia farmakologiia. 63(4) |
ISSN: |
0869-2092 |
Popis: |
Beditin, or 2-(2-amino-4-thiazolyl)-1,4-benzodioxane hydrochloride, is a new benzodioxane derivative possessing antihypoxant and alpha 2-adrenoreceptor blocker properties. In contrast to idazoxan, a well-known alpha 2-adrenoreceptor blocker, beditin (3 mg/kg) significantly increases the circulation rate and decreases the blood vessel resistance in various brain structures of rats and cats without considerably changing their systemic hemodynamic indices. Upon a one-side ligation of the common carotid artery in rats, beditin prevented a sharp increase in the lactate dehydrogenase activity and a growth in the content of free ammonia in the brain, which are characteristic of the ischemic states. The ammonia-eliminating effect of beditin is related to an increase in the glutamate dehydrogenase activity in the reductive amination reaction. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|